Notes from the Field: Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months - California, January-March, 2023

MMWR Morb Mortal Wkly Rep. 2024 Jan 5;72(5253):1390-1391. doi: 10.15585/mmwr.mm725253a2.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use
  • California / epidemiology
  • Humans
  • Tuberculosis* / drug therapy

Substances

  • Antitubercular Agents